Clinical Trials Directory

Trials / Completed

CompletedNCT04510376

Allergy Potential of Omeza Collagen Matrix in Human Subjects Using the Skin Prick Method

A Safety Study to Assess the Allergy Potential of Omeza Collagen Matrix in Human Subjects Using the Skin Prick Method

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
25 (actual)
Sponsor
Omeza, LLC · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Single-center, monadic, one day study utilizing the skin prick method to assess the allergy potential of Omeza Collagen Matrix in Human Subjects

Conditions

Interventions

TypeNameDescription
DEVICETest ArticleOmeza Collagen Matrix
OTHERPositive Control1.0 mg/mL Histamine Base
OTHERNegative ControlAqueous Negative Control

Timeline

Start date
2019-11-14
Primary completion
2019-11-14
Completion
2019-11-14
First posted
2020-08-12
Last updated
2020-08-12

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT04510376. Inclusion in this directory is not an endorsement.

Allergy Potential of Omeza Collagen Matrix in Human Subjects Using the Skin Prick Method (NCT04510376) · Clinical Trials Directory